Information
-
Trademark
-
88000887
-
International Classifications
-
Filing Date
June 14, 2018
6 years ago
-
Transaction Date
August 15, 2022
2 years ago
-
Status Date
August 15, 2022
2 years ago
-
Published for Opposition Date
May 14, 2019
5 years ago
-
Location Date
January 12, 2022
3 years ago
-
Status Code
606
-
Current Location
INTENT TO USE SECTION
Employee Name
MICKLEBURGH, LINDA BOH
-
Attorney Docket Number
1338.16PROFE
Attorney Name
Bradley P. Hartman
Law Office Assigned Location Code
L60
-
Owners
Mark Drawing Code
4000
Mark Identification
PROFERO
Case File Statements
- GS0051: Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
- GS0011: Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
- TR0010: The English translation of "PROFERO" in the mark is "DELAY".
- GS0441: Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions
- GS0421: Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
Case File Event Statements
-
8/15/2022 - 2 years ago
38 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
8/15/2022 - 2 years ago
37 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
1/13/2022 - 3 years ago
36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/12/2022 - 3 years ago
35 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
1/5/2022 - 3 years ago
34 - SOU EXTENSION 5 FILED
Type: EXT5
-
1/12/2022 - 3 years ago
33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
1/5/2022 - 3 years ago
32 - TEAS EXTENSION RECEIVED
Type: EEXT
-
7/6/2021 - 3 years ago
31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
7/2/2021 - 3 years ago
30 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
7/2/2021 - 3 years ago
29 - SOU EXTENSION 4 FILED
Type: EXT4
-
7/2/2021 - 3 years ago
28 - TEAS EXTENSION RECEIVED
Type: EEXT
-
12/24/2020 - 4 years ago
27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/22/2020 - 4 years ago
26 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
12/22/2020 - 4 years ago
25 - SOU EXTENSION 3 FILED
Type: EXT3
-
12/22/2020 - 4 years ago
24 - TEAS EXTENSION RECEIVED
Type: EEXT
-
7/3/2020 - 4 years ago
23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
7/1/2020 - 4 years ago
22 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
7/1/2020 - 4 years ago
21 - SOU EXTENSION 2 FILED
Type: EXT2
-
7/1/2020 - 4 years ago
20 - TEAS EXTENSION RECEIVED
Type: EEXT
-
12/18/2019 - 5 years ago
19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/16/2019 - 5 years ago
18 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
12/16/2019 - 5 years ago
17 - SOU EXTENSION 1 FILED
Type: EXT1
-
12/16/2019 - 5 years ago
16 - TEAS EXTENSION RECEIVED
Type: EEXT
-
7/9/2019 - 5 years ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
5/14/2019 - 5 years ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
5/14/2019 - 5 years ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
4/24/2019 - 5 years ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/1/2019 - 5 years ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/13/2019 - 5 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/13/2019 - 5 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/11/2019 - 5 years ago
8 - ASSIGNED TO LIE
Type: ALIE
-
3/8/2019 - 5 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/10/2018 - 6 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/10/2018 - 6 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/10/2018 - 6 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
9/4/2018 - 6 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/20/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
6/18/2018 - 6 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP